These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33039629)
1. Metabolite profiling and evaluation of CYP450 interaction potential of 'Trimada'- an Ayurvedic formulation. Kar A; Mukherjee PK; Saha S; Banerjee S; Goswami D; Matsabisa MG; Charoensub R; Duangyod T J Ethnopharmacol; 2021 Feb; 266():113457. PubMed ID: 33039629 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of herb-drug interaction of a polyherbal Ayurvedic formulation through high throughput cytochrome P450 enzyme inhibition assay. Pandit S; Kanjilal S; Awasthi A; Chaudhary A; Banerjee D; Bhatt BN; Narwaria A; Singh R; Dutta K; Jaggi M; Singh AT; Sharma N; Katiyar CK J Ethnopharmacol; 2017 Feb; 197():165-172. PubMed ID: 27457692 [TBL] [Abstract][Full Text] [Related]
3. CYP450 mediated inhibition potential of Swertia chirata: An herb from Indian traditional medicine. Ahmmed SM; Mukherjee PK; Bahadur S; Harwansh RK; Kar A; Bandyopadhyay A; Al-Dhabi NA; Duraipandiyan V J Ethnopharmacol; 2016 Feb; 178():34-9. PubMed ID: 26657265 [TBL] [Abstract][Full Text] [Related]
4. Safety assessment of selected medicinal food plants used in Ayurveda through CYP450 enzyme inhibition study. Kar A; Pandit S; Mukherjee K; Bahadur S; Mukherjee PK J Sci Food Agric; 2017 Jan; 97(1):333-340. PubMed ID: 27030208 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 inhibitory potential and RP-HPLC standardization of trikatu--a Rasayana from Indian Ayurveda. Harwansh RK; Mukherjee K; Bhadra S; Kar A; Bahadur S; Mitra A; Mukherjee PK J Ethnopharmacol; 2014 May; 153(3):674-81. PubMed ID: 24690772 [TBL] [Abstract][Full Text] [Related]
6. Metabolism-mediated interaction potential of standardized extract of Bahadur S; Mukherjee PK; Milan Ahmmed SK; Kar A; Harwansh RK; Pandit S Indian J Pharmacol; 2016; 48(5):576-581. PubMed ID: 27721546 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay. Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427 [TBL] [Abstract][Full Text] [Related]
9. Interaction potential of Trigonella foenum graceum through cytochrome P450 mediated inhibition. Ahmmed SM; Mukherjee PK; Bahadur S; Kar A; Mukherjee K; Karmakar S; Bandyopadhyay A Indian J Pharmacol; 2015; 47(5):530-4. PubMed ID: 26600643 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of cytotoxic, genotoxic and CYP450 enzymatic competition effects of Tanzanian plant extracts traditionally used for treatment of fungal infections. van den Bout-van den Beukel CJ; Hamza OJ; Moshi MJ; Matee MI; Mikx F; Burger DM; Koopmans PP; Verweij PE; Schoonen WG; van der Ven AJ Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):515-26. PubMed ID: 18331392 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis /LC-MS/MS. Zambon S; Fontana S; Kajbaf M Drug Metab Lett; 2010 Aug; 4(3):120-8. PubMed ID: 20642444 [TBL] [Abstract][Full Text] [Related]
12. Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS. Di L; Kerns EH; Li SQ; Carter GT Int J Pharm; 2007 Apr; 335(1-2):1-11. PubMed ID: 17137735 [TBL] [Abstract][Full Text] [Related]
13. Bush mint (Hyptis suaveolens) and spreading hogweed (Boerhavia diffusa) medicinal plant extracts differentially affect activities of CYP1A2, CYP2D6 and CYP3A4 enzymes. Ekow Thomford N; Dzobo K; Adu F; Chirikure S; Wonkam A; Dandara C J Ethnopharmacol; 2018 Jan; 211():58-69. PubMed ID: 28942133 [TBL] [Abstract][Full Text] [Related]
14. Reliable high-throughput method for inhibition assay of 8 cytochrome P450 isoforms using cocktail of probe substrates and stable isotope-labeled internal standards. Kozakai K; Yamada Y; Oshikata M; Kawase T; Suzuki E; Haramaki Y; Taniguchi H Drug Metab Pharmacokinet; 2012; 27(5):520-9. PubMed ID: 22498647 [TBL] [Abstract][Full Text] [Related]
15. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates. Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of potent CYP2D6 inhibitors in lotus leaves. Ye LH; He XX; Kong LT; Liao YH; Pan RL; Xiao BX; Liu XM; Chang Q J Ethnopharmacol; 2014 Apr; 153(1):190-6. PubMed ID: 24561383 [TBL] [Abstract][Full Text] [Related]
17. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations. Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274 [TBL] [Abstract][Full Text] [Related]
18. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes. Han SY; Zhao HY; Zhou N; Zhou F; Li PP J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 reaction phenotyping and inhibition and induction studies of pinostrobin in human liver microsomes and hepatocytes. Tan S; Dong Z; Zhang J; Efferth T; Fu Y; Hua X Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 28111763 [TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of alisol A and its metabolites' identification using high-performance liquid chromatography-mass spectrometry. Yu Y; Liu Z; Ju P; Zhang Y; Zhang L; Bi K; Chen X J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 941():31-7. PubMed ID: 24184833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]